MEDICUS PHARMA LTD (MDCX) Stock News

USA - NASDAQ:MDCX - CA58471K2020 - Common Stock

2.39 USD

-0.03 (-1.24%)

Last: 11/7/2025, 8:00:01 PM

2.4399 USD

+0.05 (+2.09%)

After Hours: 11/7/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MDCX Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: ACCESS Newswire

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome

11 days ago - By: Medicus Pharma

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome

11 days ago - By: Medicus Pharma

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome

a month ago - By: ACCESS Newswire - Mentions: COEP QNTM

Three Biotech Companies Redefining Value Creation Through Dual Strategies

18 days ago - By: ACCESS Newswire

Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

a month ago - By: ACCESS Newswire

Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025

a month ago - By: ACCESS Newswire

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE

5 months ago - By: Benzinga - Mentions: BLRX CLGN BWNB BURU ...

Nasdaq Down 100 Points; Chicago PMI Dips In May

a month ago - By: ACCESS Newswire

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

a month ago - By: Benzinga - Mentions: SNGX DRIO CLSD CRNX ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

2 months ago - By: ACCESS Newswire

Medicus Pharma Ltd. To Present at Brookline Capital Markets

2 months ago - By: ACCESS Newswire

Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing

2 months ago - By: ACCESS Newswire

Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

5 months ago - By: Quantum BioPharma - Mentions: QNTM -

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari